Welcome to our dedicated page for Cellebrite Di news (Ticker: CLBTW), a resource for investors and traders seeking the latest updates and insights on Cellebrite Di stock.
The CLBTW news page on Stock Titan aggregates coverage related to Cellebrite DI Ltd., the underlying company for the CLBTW warrants. Cellebrite’s ordinary shares trade on Nasdaq under the symbol CLBT, and the company regularly issues press releases that are furnished to the SEC on Form 6-K. These announcements provide insight into its digital investigation and intelligence business, financial performance and strategic initiatives.
Readers can expect news about Cellebrite’s AI-powered Digital Investigation Platform, which the company says enables customers to lawfully access, collect, analyze and share digital evidence in legally sanctioned investigations while preserving data privacy. Coverage often highlights how thousands of public safety organizations, intelligence agencies and businesses use its digital forensic and investigative solutions across cloud, on-premises and hybrid deployments.
Company updates frequently include quarterly financial results, commentary on annual recurring revenue and subscription trends, and discussions of non-GAAP metrics and key performance indicators. Other news items describe product and platform developments, such as enhancements to its Guardian suite, Inseyets digital forensics software, Pathfinder investigative analytics and the Cellebrite Government Cloud, which is progressing through the FedRAMP process with U.S. Department of Justice sponsorship.
Strategic announcements have also covered the agreement to acquire, and subsequent completion of the acquisition of, Corellium, a provider of Arm-based virtualization software, along with integrations that expand mobile virtualization and device analysis capabilities. Additional stories highlight partnerships and initiatives like the integration of NCMEC’s CyberTipline hash value list into Inseyets to support child exploitation investigations, as well as events such as the C2C User Summit and Digital Justice Awards.
By following CLBTW-related news, investors and observers gain context on Cellebrite’s operational focus, technology roadmap, governance developments and regulatory milestones that may be relevant when evaluating the warrants linked to CLBT.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Cellebrite DI Ltd. (Nasdaq: CLBT) announced the appointment of Mark Fitzsimons as Managing Director for its Asia-Pacific (APAC) operations, effective April 17, 2023. Based in Singapore, Fitzsimons brings over 25 years of B2B enterprise software sales and strategy experience, having previously worked with companies like Everise and Software AG.
The company's CEO, Yossi Carmil, emphasized Fitzsimons' expertise as critical for Cellebrite's growth in APAC, particularly in addressing law enforcement's digital investigation needs. Fitzsimons aims to enhance the company's mission by delivering exceptional digital intelligence solutions across the region.
Cellebrite (NASDAQ: CLBT) will announce its first-quarter 2023 financial results on May 10, 2023, before the market opens. Following the release, the company will host a live conference call at 8:30 a.m. ET to review the results and discuss its full-year outlook. Investors can access the call via phone at 203-518-9814 or through a live webcast. Historical financial data will also be made available on the company’s investor relations website. Cellebrite specializes in Digital Intelligence solutions, aimed at enhancing legal investigations and safeguarding community privacy.